🔎 Trials Near Me

Hjem › Gliom › Missouri

Kliniske studier for Gliom i Missouri

11 studier for Gliom søker deltakere på steder i Missouri.

Byer i Missouri

Offisiell studietekst (engelsk)

A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)

  • Children's Mercy Hospitals and Clinics, Kansas City
  • Cardinal Glennon Children's Medical Center, St Louis
  • Washington University School of Medicine, St Louis
  • og 1 flere
RekruttererFase 1/2
12 Months – 21 Years · Alle kjønn · Oppdatert 1. okt. 2026 · NCT05099003

Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII

  • Washington University School of Medicine Siteman Cancer Center, St Louis
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 28. sep. 2026 · NCT07326566

A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations

  • Washington University School of Medicine in St. Louis, St Louis
RekruttererFase 1/2
Opp til 25 år · Alle kjønn · Oppdatert 25. sep. 2026 · NCT04094610

ACT001 for the Treatment of Diffuse Intrinsic Pontine Gliomas and H3K27-altered High Grade Gliomas

  • St. Louis Children's Hospital, St Louis
RekruttererFase 2
12 Months – 39 Years · Alle kjønn · Oppdatert 21. sep. 2026 · NCT06838676

HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors

  • Siteman Cancer Center at Washington University, St Louis
RekruttererFase 1
36 Months – 22 Years · Alle kjønn · Oppdatert 4. sep. 2026 · NCT03911388

SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)

  • Washington University, St Louis
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 28. aug. 2026 · NCT05303519

PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma

  • St. Louis Children's Hospital, St Louis
RekruttererFase 2
Alder 3 til 39 · Alle kjønn · Oppdatert 24. aug. 2026 · NCT05096481

Trametinib and Everolimus for Treatment of Pediatric and Young Adult Patients With Recurrent Gliomas (PNOC021)

  • Washington University in St. Louis, St Louis
RekruttererFase 1
Alder 1 til 25 · Alle kjønn · Oppdatert 18. aug. 2026 · NCT04485559

A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations

  • Mosaic Life Care at Saint Joseph - Medical Center, Saint Joseph
RekruttererFase 2
Alder 8 og eldre · Alle kjønn · Oppdatert 27. jul. 2026 · NCT05503797

Window of Opportunity Study of DSP-0390 in Gliomas

  • Washington University School of Medicine, St Louis
RekruttererTidlig fase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 6. mai 2026 · NCT06636162

Inflammation in Primary and Secondary Malignancies of the Central Nervous System Using [C-11]-CS1P1

  • Washington University School of Medicine, St Louis
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 21. apr. 2026 · NCT07462507

Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.